chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body aches; nausea; vomiting; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021 at 7:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced MYALGIA (Body aches), NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever). At the time of the report, MYALGIA (Body aches), NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment medications not specified.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 67-year-old male patient received BNT162b2 (BNT162B2), on 06Jan2021 as dose 1, single (Batch/Lot number: unknown), in right arm, on 27Jan2021 as dose 2, single (Batch/Lot number: unknown), in right arm and on 17Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 66 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Chronic kidney disease" (unspecified if ongoing); "Arthritis" (unspecified if ongoing); "Known allergies: Shellfish" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Iodine, reaction(s): "Known allergies: Iodine". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association be-tween the event and the suspect drug cannot be excluded.
tingly sensation on left arm; some sort of numbness at night; really bad head ache and body ache; really bad head ache and body ache; continue with chills; got covid booster shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old male patient received bnt162b2 (COMIRNATY), intramuscular, administered in arm, administration date 02Dec2021 10:00 (Lot number: FJ8762) at the age of 39 years as dose 3 (booster), single for covid-19 immunisation in Pharmacy/drug store. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (1st dose, Anatomical site of injection: Arm, Route of administration: Intramuscular, Batch/Lot number: #EL3247), administration date: 10Mar2021, when the patient was 38 years old, for Covid-19 immunization; Bnt162b2 (2nd dose, Anatomical site of injection: Arm, Route of administration: Intramuscular, Batch/Lot number: #EL3247), administration date: 31Mar2021, when the patient was 38 years old, for Covid-19 immunization, reaction(s): "Sore muscles/ Muscle aches", "Chills", "Headache", "Little bit of fever". The following information was reported: IMMUNISATION (non-serious) with onset 02Dec2021 10:00, outcome "unknown", described as "got covid booster shot"; PARAESTHESIA (non-serious), outcome "unknown", described as "tingly sensation on left arm"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "some sort of numbness at night"; HEADACHE (non-serious), PAIN (non-serious), outcome "unknown" and all described as "really bad head ache and body ache"; CHILLS (non-serious), outcome "unknown", described as "continue with chills". Additional information: The patient received booster dose due to high risk of frequent institutional or occupational exposure to coronavirus (and at risk of serious covid-19 complications). Patient did not receive any prior vaccinations within 4 weeks. There was no relevant tests and no specific relevant test for thromboembolic events with thrombocytopenia.  Follow-up attempts are completed. No further information is expected.
Patient is a 85 y.o. female who presents to the ED with shortness of breath on 8/31/2021.  She reported her symptoms began on 8/19. She stated that she has been experiencing symptoms of minimal diarrhea, low grade fever, cough with green to yellow sputum and some chest pain. She stated that she tested positive for COVID-19 1 week ago and received outpatient IV casirivimab-imdevimab  treatment on 8/28. She reported a baseline wearing 2L NC oxygen at night and sometimes during the day if she needs it.   She was admitted to hospital with diagnosis of acute respiratory failure with hypoxia 2/2 to COVID-19 Pneumonia.  -O2 requirements of 2 L NC with baseline of 2 L Q hs and PRN during the day -hypoxia noted on arrival requiring 2 L continuous-- >back to baseline o2 of 2L Q HS  -Rx with dexamethasone -did not qualify for Remdesivir -Rx with Vit C/D/Zinc -day of dc feels well and without chest pain or sob
Arm hurt during and immediately after injection in left arm.  Seemed to be in muscle. Very painful to dress + undress, lift things, reach for seatbelt in car, put coat on. Sleep is poor due to extreme pain when lying down. Took Advil every 6 - 12 hours. Pain continues. Saw doctor 12/10/12 who prescribed I take methylprednisolone then followed by diclofenac sodium. Also prescribed physical therapy. Pain has diminished SLIGHTLY while on medication.
I was given the HEP B vaccine, shot #3.  About 1 hours late, faster reaction to the previous 2 shots, I experienced the same pain from the shoulder blade up through to my head that I did from the first and second shot of the HEP B vaccine.  I couldn't move, and my hearing was muffled. I couldn't turn my head. The temporary paralysis feeling lasted 4 hours, but the pain lasted 7 days.  The most severe pain was at the top of my spine just before my head just like with shot #1 and #2.  It felt like someone was pushing their thumb on my spinal cord.  The difference with this was some shortness of breath. Just like with the other 2 shots, no one believed me, saying this was all normal, so there was no treatment. I had to wait it out.
approx 3yrs p/vax pt devel mild case of chickenpox w/approx 10 lesions
Roughly 45 hrs after receiving the second shot on 3/26/21, I woken up to very noticeable / semi loud constant ringing in both ears.  The volume of the ringing had reduced during the day, but it was constant until the evening when it went away.   On 4/12/21, I had woken up to the ringing again and has been constant in both ears ever since and still continues to this day, 4/26/21.  It is very noticeable and a loud high pitch ringing that occasionally seems to vary in volume, but still very unnerving as it has been almost 2 weeks of constant tinnitus.
several episodes of syncope beginning 14FEB96;inj site painful but not red;15FEB96 fainted @ work & evaluated by MD;
Felt cramps in my lower abdomen, then in my mid back. Put heat on my back. Then I started to feel very nauseous and light headed, dizzy. Shortly felt a burning feeling in my chest and  collar bones, that spread to my head. My head started to burn, it felt like it was on fire, along with my neck and chest. I felt dizzy, like i was going to faint, the burning and dizziness lasted for about 5 minutes. Shortly after i felt like my throat closed up and I was having very labored breaths. The burning feeling in my body and dizziness came back, along with not feeling like i could breathe well. I went to an ER, they gave me an IV with Benadryl, and I started to feel well enough 2 hours later to go home.
Patient came into pharmacy to receive 2nd dose of Shingrix but received 3rd dose of Pfizer covid vaccine, advised patient of possibility of increased side effects from incorrectly receiving 3 covid vaccines. Currently, no side effects have been reported
Sore throat, dizziness, uncontrollable sneezing, severe headache, loss of smell, extreme chills and shivering, diarrhea, vomiting, body aches to the extreme, confusion, weakness and extreme tiredness now on day 5
feeling ill; This spontaneous case was reported by a nurse and describes the occurrence of MALAISE (feeling ill) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2022, the patient experienced MALAISE (feeling ill). At the time of the report, MALAISE (feeling ill) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
7/30/21 Pt had 4-5 episodes of seizure-like activity throughout the day. Parents took him to the ER where doctors there doctors witnessed approx 20 secs of legs jerking. Pt admitted to peds floor floor. EEG done: done; focal onset seizure from C2-C4, Jerking of legs, staring starting off Patient started on Keppra
myalgia, arthralgia, fatigue, tremors, transient pruritic rash, fever, transient visual field, h/a 15FEB;scitoma ;rx Ibuprofen;
3 days after I took my first Moderna vaccine on 2/4/2021,I had a reaction on Sunday, 2/7/21.  The reaction was at 5:00 p.m. on 2/7, I did not feel well and my legs felt shaky and my blood pressures which are always in the 120 or 110 range over 70s or 60s were 164/86, 141/96, 199/79 and 156/132.  The paramedics were called and they said it was the vaccine and my blood pressure was 151/70 at 6:15 pm..  I started to feel better but at 8 pm the same day, 2/7 m pressures from 8 pm to 11:30 pm were 158/83, 191/87, 146/106 and 144/74 and 130/67 and I was feeling better.  On Monday  2/8 my blood pressure readings were normal.  On Tuesday, 2/9/2021 I did not feel well at 5:00 a.m.  At 5:55 a.m. my blood pressure was 188/85, 137/100, 169/89 and then was normal.  The last time it happened was on Saturday, 2/13 and my pressures were 160/127 at 3:20 a.m. and 138/97.  My pulse was always normal.
Extra energy; Hyperactive; More awake; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 11Mar2021 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 14Feb2021 at 12:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. On an unknown date in Mar2021, the patient experienced extra energy, was hyperactive and more awake. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events extra energy, hyperactive and more awake was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Warm, painful, swollen, red spot at injection site, only about one inch in diameter and left a bruise after a week of the symptoms.
This case was reported by a consumer via call center representative and described the occurrence of therapeutic response decreased in a adult female patient who received Meningococcal ACWY Vaccine (potential MENVEO). Co-suspect products included Meningococcal B vaccine. On an unknown date, the patient received Meningococcal ACWY Vaccine (potential MENVEO) at an unknown dose and Meningococcal B vaccine at an unknown dose. On an unknown date, an unknown time after receiving Meningococcal ACWY Vaccine (potential MENVEO) and Meningococcal B vaccine, the patient experienced therapeutic response decreased and inappropriate age at vaccine administration. On an unknown date, the outcome of the therapeutic response decreased and inappropriate age at vaccine administration were unknown. It was unknown if the reporter considered the therapeutic response decreased to be related to Meningococcal ACWY Vaccine (potential MENVEO) and Meningococcal B vaccine. Additional details were provided as follows: The age at vaccination was not reported. The patient was not sure what brand she received, but BEXSERO sounded familiar to her. The patient had received multiple doses of the multiple serogroup vaccine, and had received two different brands. The first vaccine was appropriate for patient's age group, but she had low titers afterwards, which led the patient to have a low titers. The patient then received the one which was approved for a younger age group than the patient's age, which led to inappropriate age at vaccine administration. This vaccine worked well for the patient and her titers were good. It was reported that, every two weeks the patient received infusions of a medication that leaves her at high risk for developing a meningococcal infection, so it was important for her to maintain good titer levels. This was why the patient had received multiple injections with the multiple serogroup vaccine. The patient wants to make sure her titers for serotype B are still high, but cannot find a place which could do the titer.
Information has been received from a physician and the office manager concerning a 12 month old male patient who on 01-APR-2009, was vaccinated with PNEUMOVAX (lot # 661934/1441X) instead of PREVNAR by mistake due to an office error. It is unknown if the patient sought medical attention. Follow up information was received from the physician which reported that the patient was vaccinated IM with PNEUMOVAX (lot # 661934/1441X). There was no illness at the time of vaccination. No reactions or adverse events were reported. The patient did not seek medical attention. This is one of several reports from the same source. Additional information is not expected.
A report was received from a health care professional on 10/30/03, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/1/03: Follow up information received from a health care professional indicated that a 9 month old male vaccinee inadvertently received Fluvirin on 10/28/03 and had not experienced any adverse event at the time of the report. No follow up pending, all information received. Cross reference with: PJP200300957, PJP200400013, PJP200400014. PJP200400015, PJP200400016, PJP200400017, PJP200400018, PJP200400019, PJP200400020, PJP200400022, PJP200400023, PJP200400024.
A spontaneous report was received from a pharmacist concerning 43-year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) administered with a 5/8-inch (subcutaneous) needle. The patient's medical history was not provided. No relevant concomitant medications were reported. On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Lot number 026L20A) for prophylaxis of COVID-19 infection. On an unknown date, the patient was administered a vaccine using a 5/8-inch (subcutaneous) needle. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The event, vaccine administered with a 5/8-inch (subcutaneous) needle, was considered recovered/resolved.; Reporter's Comments: This report refers to a 43-year old, female patient who received their first of two planned doses of mRNA-1273 (lot # 026L20A), reporting Product administration error.  There were no reported AEs associated with this case of Product administration error.
Shot 1: Pain in arm, diarhea after 40 mins, ~ 24 hours of fatigue. No big deal.  Shot 2: Pain in arm, pain worsening over 4 hours, numbness + burning in the hand. 3 weeks and counting.  Can't feel my fingers in right hand, burning sensation, no pain in forearm/arm.
Shortness of breath about 18 hours alter; Inflammation; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 08Apr2021 at 10:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, hypogonadism and hypothyroidism. Patient did not report any known allergies to food, medications or other products. Concomitant medications included metformin hydrochloride (METFORM), hydrochlorothiazide, lisinopril (LISINOPRIL/HCTZ), levothyroxine (MANUFACTURER UNKNOWN) and testosterone (MANUFACTURER UNKNOWN); all from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG204) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 11:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021 at 08:45, the patient experienced shortness of breath about 18 hours alter and at 06:00, experienced inflammation. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events shortness of breath about 18 hours alter and inflammation were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
I woke up at 2AM with a funny sensation in my esophagus, it felt tight and hot, the trouble breathing woke me up, I had chills, shaking, but no fever, extreme muscle weakness, I could barely walk steps. My main issue was the trouble breathing. Went to the ER and pulse/ox was 96/97 so it was good my oxy saturation was really good. They just observed me for some hours and by 5AM and I discharged and on Saturday I woke up ok but felt weak. I still feel some muscle weakness.
second dose produced sore arm, nausea and a headache; second dose produced sore arm, nausea and a headache; second dose produced sore arm, nausea and a headache; This is a spontaneous report from a contactable Nurse. A 33-year-old female patient received the second dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number EJ1485), via an intramuscular route of administration, anatomical location Arm left Deltoid left On 12Jan2021 12:55 at single dose for Covid-19 immunization. The patient medical history included HSV I Onset date 01Apr2008 Ongoing outbreaks 6xyear, exacerbated with viral infection, Onset date: 05Apr2020 no change in breastfeeding frequency or output, on 19Dec2020 Viral illness, sore throat, congestion. 23Dec2020 05:00 soreness, headache, myalgias fatigue. The patient historic vaccine include first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number EJ1685, Expiration Date: unknown), via an intramuscular route of administration, On 22Dec2020 at single dose for COVID-19 immunization. Concomitant medication included Prenatal vitamin DHA Start date: 03Aug2019 Indication: dietary supplement, ibuprofen 200-400mg 12Jan2021 Indication: Body aches, Tylenol 500mg Indication: headaches. The patient experienced second dose produced sore arm, nausea and a headache. Vaccination facility type, at Hospital. On 21Dec2021, the patient underwent lab test SARS-CoV-2 test Nasal Swab result-negative. The outcome of event was recovering.
Vaccine had expired prior to being administered.  No adverse reaction noted.  Physician gave order to administer new vaccination.
Was administered a Moderna vaccine with expiry date 10/15/2021.  She was monitored for 15min after injection.  No complications or adverse events were noted.
Fever, Chills, Diarrhea, mild sore throat, mild breathing impairment, severe fatigue and lack of appetite. All these side effects started 2 days after vaccination 5/13/2021 and have kept me soaking wet, cold, and in bed through right now 5/15/2021 at 10:25pm
5 minutes after receiving the vaccine, patient became flushed. She also stated that she had a sore throat without SOB or difficulty swallowing. She was able to drink water without difficulty. Her airway was patent and oropharynx was normal on exam. She had no stidor on exam. Patient was advised to seek care at the ED, but she did not.
Approx 30 min s/p vaccinations pt became very lethargic, skin very red all over, ears and face hot (warm to touch) vomiting, seems disoriented. Sent to ER.
Initial case received from a non healthcare professional on 30 September 2013. A patient whose demographics were not reported had received a dose of FLUZONE Intradermal (batch number: UT4470AA, expiry date 03/20/13, dose number, route and site of administration was not reported) on an unspecified date. The patient's medical history was not reported. It was reported that after vaccination on an unspecified date the patient experienced unspecified adverse reaction. Details of laboratory investigations and treatment medications were not reported. At the time of this reporter, the outcome of the event was not reported. List of documents held by sender: none.
8/11/11 patient received Tdap & MENACTRA. On 8/13/11 patient had warmth & swelling on 50% of (L) deltoid.
04/16 I began a severe headache and dizziness. The headache was continuing to grow and not let up. It began causing blurred vision. On 04/20 the doctors discovered that my cholesterol levels and blood pressure was high which is extremely abnormal for me. On 04/21 I was given Lipitor. On 04/22 I woke very nauseous, dizziness, tremors and neuropathy in my hands, arms, feet and legs. I was barely able to walk and kept falling because of this. I had gone to see my doctor again this day and they called an ambulance and had me escorted to the ER. They did lots of tests and blood work. On 5/03 I saw the doctor again and I still had the headaches, blurred vision, neuropathy and was falling. Along with my blood pressure continuing to be abnormally high around 184/96. I had an MRI done on 05/18 and they found some swelling and a few other issues. On 05/25 I had more labs done but I do not remember what they were. On 05/28 I was still continuing to have tremors, neuropathy and headaches. In September I still had neuropathy in both feet, legs, arms and hands. Not consistent like it was but still have it some days. Since this I have had an EEG and we are still waiting on the results to come back for that. The headaches are still here, the neuropathy is now mainly just in my hands, I can go about 10 days without falling now but otherwise it is mostly minor now because it comes and goes, and I am still having uncontrolled sky rocketing blood pressure which I have never had an issue with before this.